(Q104470299)
Statements
A methodology for developing key events to advance nanomaterial-relevant adverse outcome pathways to inform risk assessment (English)
1 reference
25 September 2023
Nanomaterials
1 reference
12 February 2021
Nanotechnology
1 reference
12 February 2021
Risk assessment
1 reference
12 February 2021
Airborne particulates
1 reference
12 February 2021
Lung disorders
1 reference
12 February 2021
Biological effects
1 reference
12 February 2021
Sabina Halappanavar
Indrani Mahapatra
Harald F Krug
Jo Anne Shatkin
14 December 2020
1 reference
1 reference